Seagen

wikipedia:Seagen (formerly Seattle Genetics, Inc.) (1997) (Nasdaq 100) Subsidiary from Pfizer since March 2023 acquire Seagen for a total enterprise value of around $43 billion.

• Brentuximab vedotin and other antibody-drug conjugates

Related

• Merck & Co.

See also

• Pfizer, mRNA, Albert Bourla, Pfizer–BioNTech COVID-19 vaccine, Seagen, Mike Yeadon
• Genetics
• Pharma, AbbVie, DaVita, Novartis, Pfizer (Seagen), Takeda Pharmaceutical Company, Merck & Co., Bayer, Bristol Myers Squibb